What Obesity Drugs' Medicare Change Could Mean For Lilly, Novo
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information solely for informational and educational purposes and does not offer recommendations or solicitations to buy or sell securities.
- The data is sourced from what are believed to be reliable providers, but accuracy, timeliness, and suitability are not guaranteed, including information in closed captioning.
- Past investment performance is not indicative of future results, and authors or presenters may have ownership in the stocks they discuss.
- No warranties are made regarding the advisability of any investment or strategy, and information is subject to change without notice.
- Real-time prices come from Nasdaq Last Sale, with ownership and estimate data provided by LSEG and FactSet, respectively; trademarks mentioned belong to Investor’s Business Daily, LLC.
